EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer

Jesenia M Perez, Justin Hwang iD, Britt K Erickson, Stefani N Thomas iD

Clinical and Translational Medicine · 2026-11 · 16 (11)

DOI: 10.1002/ctm2.70890 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 01.11.2026. Verfasst von Jesenia M Perez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
  • Department of Obstetrics, Gynecology and Women's Health, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.

ORCID-Profile: Justin Hwang, Stefani N Thomas

Förderung

  • NCI NIH HHS

Zitieren

APA

Perez, J. M., Hwang, J., Erickson, B. K., & Thomas, S. N. (2026). Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer. Clinical and Translational Medicine, 16(11). https://doi.org/10.1002/ctm2.70890

Vancouver

Perez JM, Hwang J, Erickson BK, Thomas SN. Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer. Clinical and Translational Medicine. 2026;16(11). doi:10.1002/ctm2.70890

BibTeX
@article{Perez2026,
  author = {Perez, Jesenia M and Hwang, Justin and Erickson, Britt K and Thomas, Stefani N},
  title = {Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {11},
  doi = {10.1002/ctm2.70890}
}
Kostenlos starten →